Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0018 | 1 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0017 | 1 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |